Sleep apnea devices market to reach $12.54B by 2030

The Business Research Company says the sleep apnea devices market is expanding on rising obesity, more sleep disorder awareness and broader use of portable and home-based devices. The market is projected to grow from $8.37 billion in 2025 to $12.54 billion by 2030, with North America leading in 2025 and Asia-Pacific expected to grow fastest.

Why it matters: - Sleep apnea devices are tied to a growing health burden as obesity, aging populations and sleep disorder awareness increase demand for diagnosis and treatment. - The market’s projected rise to $12.54 billion by 2030 points to continued growth for CPAP machines, portable devices and non-invasive alternatives. - The shift toward home healthcare and home-based diagnosis could change where patients are tested and treated.

What happened: - The Business Research Company released its 2026 sleep apnea devices market report on August 26, 2026. - The report estimates the global market at $8.37 billion in 2025 and $9.05 billion in 2026. - The report forecasts the market will reach $12.54 billion by 2030. - North America held the largest share of the market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - Sleep apnea devices are primarily continuous positive airway pressure, or CPAP, machines. - CPAP devices deliver air pressure through a mask to keep the upper airway open during sleep. - The devices are designed to prevent snoring and reduce apnea episodes caused by airway collapse. - The report links recent growth to higher sleep apnea awareness, rising obesity rates, more sleep laboratories, CPAP improvements and wider insurance coverage. - Future growth is expected to come from the home healthcare sector, an aging population, portable sleep devices, higher healthcare spending and better sleep monitoring technology. - The report highlights home-based sleep apnea diagnosis, portable CPAP devices, non-invasive oral appliances, patient comfort and compliance, and more sleep clinics and diagnostic centers as major trends. - The obesity link is central to the market outlook because higher body mass increases the risk of sleep apnea. - A May 2025 report from the UK’s Office for Health Improvement & Disparities found 64.5% of adults in England were overweight or obese in 2023–2024, up from 64.0% a year earlier. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report package also includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel forecasting dashboards, market hotspots infographics, and key technology and future trend analysis. - The company offers a free sample of the report and a full version online: Download a free sample and View the full report.

Between the lines: - The report suggests the market is moving from hospital-centered care toward more portable, home-based and patient-friendly treatment options. - The emphasis on compliance and comfort signals that device usability is becoming as important as basic clinical performance. - The Asia-Pacific growth outlook reflects where future demand is likely to expand fastest, even as North America remains the current leader.

What's next: - The report expects continued demand growth through 2030 as sleep apnea diagnosis broadens and treatment options diversify. - Market momentum will likely depend on how quickly providers adopt portable devices, oral appliances and home testing. - The company’s updated forecasting tools and market scoring products suggest more frequent tracking of category opportunities and regional shifts.